Midatech Pharma PLC (MTP): Price and Financial Metrics

Midatech Pharma PLC (MTP): $1.14

0.26 (-18.52%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add MTP to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#350 of 502

in industry

MTP Price/Volume Stats

Current price $1.14 52-week high $5.25
Prev. close $0.35 52-week low $0.29
Day low $1.14 Volume 41,075
Day high $1.40 Avg. volume 57,354
50-day MA $0.56 Dividend yield N/A
200-day MA $1.96 Market Cap 24.71M

MTP Stock Price Chart Interactive Chart >


Midatech Pharma PLC (MTP) Company Bio


Midatech Pharma PLC focuses on the development and commercialization of multiple, high-value, targeted therapies for major diseases with high unmet medical need in the nanomedicine field.


MTP Latest News Stream


Event/Time News Detail
Loading, please wait...

MTP Latest Social Stream


Loading social stream, please wait...

View Full MTP Social Stream

Latest MTP News From Around the Web

Below are the latest news stories about MIDATECH PHARMA PLC that investors may wish to consider to help them evaluate MTP as an investment opportunity.

Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity

Biodexa Pharmaceuticals PLC (AIM:BDRX; Nasdaq:BDRX), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has today issued to various investors 18,636,190 new ordinary shares of £0.02 each in the Company ("New Ordinary Shares"), pursuant to the exercise notices in respect of 1,738,136 A Warrants and 1,989,102 B Warrants received yesterday.

Yahoo | March 29, 2023

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, is pleased to announce a new research programme coded MTD217 focusing on developing new therapeutic options for metastatic cancers with high unmet needs.

Yahoo | March 27, 2023

Midatech Pharma PLC Announces Results of General Meeting

Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, is pleased to announce that at the general meeting of the Company held earlier today (the "General Meeting"), all resolutions put to the Company's shareholders ("Shareholders") were duly passed.

Yahoo | March 24, 2023

Midatech Pharma PLC Announces Further re: Notice of General Meeting

Further to the announcement made on 8 March 2023 providing notice of a general meeting (the "GM") of the Company to be held on 24 March 2023, and the publication and despatch of a circular to shareholders containing notice of the resolutions to be considered at the GM (the "Notice") and form of proxy (the "Form of Proxy"), the Company announces the following corrections to certain typographical errors identified within the Notice and Form of Proxy:

Yahoo | March 10, 2023

Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting

Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, announces, further to the Company's announcements of 9 February and 15 February 2023, that a circular (the "Circular") and formal Notice of General Meeting was posted to shareholders yesterday and will be made available on the Company's website at: www.midatechpharma.com/investors/shareholder-information.

Yahoo | March 8, 2023

Read More 'MTP' Stories Here

MTP Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -97.07%
5-year -99.45%
YTD N/A
2023 0.00%
2022 -81.24%
2021 -43.85%
2020 -45.74%
2019 -55.53%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!